Evidence map›Paper›PMID 40106206›Full record

ArticleAnnals of nuclear medicine2025

Physiological bio-distribution of

Nuh Filizoglu, Salih Ozguven, Selin Kesim, Kevser Oksuzoglu, Feyza Caglıyan, Tunc Ones, Fuat Dede, Halil Turgut Turoglu, Tanju Yusuf Erdil

Abstract read
In one paragraph

Article in Annals of nuclear medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nuh FilizogluDepartment of Nuclear Medicine, University of Health Sciences, Kartal Dr. Lutfi Kirdar City Hospital, D-100 Güney Yanyol No:47 Cevizli Mevkii, Kartal, 34865, Istanbul, Turkey. nuhfilizoglu@gmail.com.ORCID http://orcid.org/0000-0002-9139-9752
Salih OzguvenDepartment of Nuclear Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Selin KesimDepartment of Nuclear Medicine, University of Health Sciences, Kartal Dr. Lutfi Kirdar City Hospital, D-100 Güney Yanyol No:47 Cevizli Mevkii, Kartal, 34865, Istanbul, Turkey.
Kevser OksuzogluDepartment of Nuclear Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Feyza CaglıyanDepartment of Nuclear Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Tunc OnesDepartment of Nuclear Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Fuat DedeDepartment of Nuclear Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Halil Turgut TurogluDepartment of Nuclear Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Tanju Yusuf ErdilDepartment of Nuclear Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveSomatostatin receptors (SSTRs) are G protein-coupled transmembrane receptors that serve as a specific molecular target for a number of radiopharmaceuticals utilized for the imaging of neuroendocrine tumors (NETs).

methodsWe retrospectively analyzed 247 consecutive

resultsThe highest levels of physiological uptake were observed in the spleen across all age groups, except for infants, who demonstrated the highest SUV values in the kidneys.

conclusionThis study presents the bio-distribution pattern of

Indexed as

OctreotideOrganometallic CompoundsAdolescentChildChild, PreschoolFemaleHumansInfantInfant, NewbornMalePositron Emission Tomography Computed TomographyRetrospective StudiesTissue DistributionOctreotideOrganometallic Compounds68Ga-DOTA-TATEGrowth platesPediatric patientsPET/CTSomatostatin receptors

Identifiers

PMID40106206
PMCPMC12174203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.